Innovation and commercialisation
Early stage technology companies often present challenges that are quite different from other industries. While start-ups are often seen as agile and innovative, their smallness and newness are often rather ‘liabilities’. Start-ups face the challenges of the high cost of capital, scarcity of managerial skills and intense competition. What are some of the governance issues that Directors face in the innovation sector?
Colin will also share some examples of innovations from Plant and Food Research and welcomes questions at this breakfast discussion.
Colin is actively involved with investment, development and commercial implementation of novel technology companies. Following 10 years in veterinary clinical practice he held a number of senior executive roles in the primary, secondary and tertiary health care sectors and was a founding partner in health consulting and investment banking services firm Medicus Capital. Relevant roles have included GM Clinical Support Services Health Waikato, CEO of Integrated Care IT company HSAGlobal, CEO of Otago Innovation, the commercialisation arm of the University of Otago and Executive Director- Group Strategy of a healthcare REIT.
Colin chairs the Boards of Tiro Medical,Upstream Medical Technologies and Ember Wellbeing Trust. He is a director of MARS Bioimaging, the NZ Institute for Plant and Food Research and The NZ Institute for Minerals to Materials Research. He is a graduate of The University of Auckland Business School, an SEP alumnus of the Stanford University Graduate School of Business and a Chartered Fellow of the NZ Institute of Directors.
Branch event cancellation policy
Regrettably, registration fees cannot be refunded when cancellations are received within two working days prior to any branch event.
The Nelson Marlborough Branch acknowledges the generous support of
Back to Nelson Marlborough branch events